Found 34 matching trials
A Prospective Study Investigating the Relationship Between Minimal Residual Disease Detection, Monitoring Frequency, and Prognosis in Non-small Cell Lung Cancer Patients Eligible for Curative Treatment. N/A Adding immune checkpoint inhibitors or molecularly targeted drugs as adjuva...
Show More Location
National Cancer Center Hospital
Learn More & Join Trial
ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness NA The goal of this performance study is to learn if treatment with neoadjuvan...
Show More Location
Allg. GynƤkologie u. gyn. Onkologie/Senologie
Learn More & Join Trial
Signatera Assessment in Early-Stage Endometrial Cancer NA The goal of this clinical trial is to assess if circulating tumor DNA can g...
Show More Location
University of Alabama at Birmingham Hospital
Learn More & Join Trial
Personalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer Patients Who Achieved Durable Response to Anti-HER2 Treatment N/A Anti-HER2 therapy, such as trastuzumab and pertuzumab, has significantly im...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Circulating Tumor DNA (ctDNA) in High Grade Upper Tract Urothelial Cancer (UTUC) N/A The study will evaluate the feasibility of collecting ctDNA data for UTUC p...
Show More Location
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy N/A Blood samples will be tested to identify circulating tumor DNA and plasma p...
Show More Location
Zhongshan Hospital Fudan University
Learn More & Join Trial
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer NA The purpose of this study is to evaluate the efficacy and safety of ctDNA-g...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab PHASE2 The purpose of this study is to investigate the use of ctDNA measurements t...
Show More Location
NYU Langone Health
Learn More & Join Trial
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas PHASE1 This is a phase 1b, prospective, single arm, non-randomized, open-label cli...
Show More Location
Chao Family Comprehensive Cancer Center, University of California, Irvine
Learn More & Join Trial
BESPOKE Study of ctDNA Guided Immunotherapy N/A This is a prospective data collection study of patients with advanced solid...
Show More Learn More & Join Trial